Chimeric receptor with NKG2D specificity for use in cell therapy against cancer and… Grant US-11873512-B2 United States of America 16 Jan 2024
Compositions and methods for CAR T cell therapy Grant US-11850262-B2 United States of America 26 Dec 2023
Compositions and methods for CAR T cell therapy Grant US-11759480-B2 United States of America 19 Sep 2023
Phospholipid ether (PLE) CAR T cell tumor targeting (CTCT) agents Grant US-11649288-B2 United States of America 16 May 2023
BISPECIFIC ANTIBODIES ENHANCING CELL MEDIATED IMMUNE RESPONSES Application WO-2022184845-A1 World Intellectual Property Organisation (WIPO) 09 Sep 2022
METHODS FOR IMPROVING FUNCTIONALITY IN NK CELL BY GENE INACTIVATION USING SPECIFIC… Application EP-4043556-A1 European Patent Office 17 Aug 2022
ARTIFICIAL TARGET CELLS FOR IN-VITRO CAR CYTOTOXICITY AND ADCC VALIDATION Application WO-2021026155-A1 World Intellectual Property Organisation (WIPO) 11 Feb 2021
CAR-expressing NK-92 cells as cell therapeutic agents Application US-10550197-B2 United States of America 04 Feb 2020
Chimeric receptor with NKG2D specificity for use in cell therapy against cancer and… Grant US-10538739-B2 United States of America 21 Jan 2020
Interleukin 15 as selectable marker for gene transfer in lymphocytes Application US-10351612-B2 United States of America 16 Jul 2019
Car-expressing NK-92 cells as cell therapeutic agents Application US-9920132-B2 United States of America 20 Mar 2018
Interleukin 15 as selectable marker for gene transfer in lymphocytes Grant US-9487800-B2 United States of America 08 Nov 2016
Tumor suppression using human placental perfusate and human placenta-derived intermediate… Grant US-9216200-B2 United States of America 22 Dec 2015
COMPOSITIONS AND METHODS RELATED TO A HUMAN CD19-SPECIFIC CHIMERIC ANTIGEN RECEPTOR (H-CAR… Application WO-2009091826-A2 World Intellectual Property Organisation (WIPO) 23 Jul 2009